Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.69
Delayed Data
As of Apr 24
 +0.04 / +1.51%
Today’s Change
1.00
Today|||52-Week Range
8.46
+5.49%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.65
Today’s open2.68
Day’s range2.66 - 2.75
Volume757,127
Average volume (3 months)989,349
Market cap$179.5M
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+17.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales26.71
Price/Book12.69

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll AG+1.28+14.85%
AKBAAkebia Therapeutics ...-0.08-0.91%
EGLTEgalet Corp+0.05+0.49%
ANTHAnthera Pharmaceutic...+0.31+6.34%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers